期刊文献+

细胞色素P450与心血管疾病的研究进展 被引量:1

Advance Research for Cytochrome 450 Enzymes and Cardiovascular Disease
下载PDF
导出
摘要 心血管疾病已成为世界上发病率最高的疾病之一。想要减少心血管疾病的发病率,明确心血管疾病的发病机制尤其重要。近年来越来越多的研究表明,细胞色素P450(Cytochrome 450 enzymes,CYP)在心血管疾病的发病过程中起重要作用。并且研究表明CYP的表达在心血管疾病的发作和进展过程中起到保护性作用,现就其研究进展作一综述。 Cardiovascular disease has become one of the most serious diseases in the world.In order to reduce the incidence of cardiovascular disease,make sure of the pathogenesis of cardiovascular disease is particularly important.In recent years,more and more studies show that Cytochrome 450 enzymes(CYP)play an important role in the pathogenesis of cardiovascular disease and CYP expression play a protective role in the onset and progression of cardiovascular disease.
作者 程龙 吴柱国
机构地区 广东医学院
出处 《中国医学创新》 CAS 2016年第14期133-136,共4页 Medical Innovation of China
关键词 细胞色素P450 心脏 活性氧簇 心血管疾病 Cytochrome 450 enzymes Heart Reactive oxygen species Cardiovascular disease
  • 相关文献

参考文献26

  • 1Edin M L,Wang Z,Bradbury J A,et al.Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart[J].FASEB J,2011,25(10):3436-3447.
  • 2Dey A,Kumar S M.Cytochrome P450 2E1 and hyperglycemiainduced liver injury[J].Cell Biol Toxicol,2011,27(4):285-310.
  • 3Zhang W,Lu D,Dong W,et al.Expression of CYP2E1increases oxidative stress and induces apoptosis of cardiomyocytes in transgenic mice[J].FEBS J,2011,278(9):1484-1492.
  • 4Bansal S,Liu C P,Sepuri N B,et al.Mitochondria-targeted cytochrome P450 2E1 induces oxidative damage and augments alcohol-mediated oxidative stress[J].J Biol Chem,2010,285(32):24 609-24 619.
  • 5Visser L E,van Vliet M,van Schaik R H,et al.The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2or CYP2C9*3 alleles on acenocoumarol or phenprocoumon[J].Pharmacogenetics,2004,14(1):27-33.
  • 6Kim I S,Jeong Y H,Park Y,et al.Platelet inhibition by adjunctive cilostazol versus high maintenance-dose clopidogrel in patients with acute myocardial infarction according to cytochrome P450 2C19 genotype[J].JACC Cardiovasc Interv,2011,4(4):381-391.
  • 7张林,王江滨.CYP2C19与质子泵抑制剂[J].国外医学(消化系疾病分册),2004,24(3):166-169. 被引量:11
  • 8Luoma P V.Cytochrome P450 and gene activation--cholesterol elimination and regression of atherosclerosis:author reply to the commentary[J].Eur J Clin Pharmacol,2009,65(1):105-106.
  • 9Luoma P V.Cytochrome P450 and gene activation--from pharmacology to cholesterol elimination and regression of atherosclerosis[J].Eur J Clin Pharmacol,2008,64(9):841-850.
  • 10Thum T,Borlak J.Mechanistic role of cytochrome P450monooxygenases in oxidized low-density lipoprotein-induced vascular injury:therapy through LOX-1 receptor antagonism[J].Circulation Research,2004,94(1):e1-13.

二级参考文献16

  • 1Abelo A, Andersson TB, Antonsson M, et al. Drug Metab Dispos, 2000 ; 28:966 - 972
  • 2Klotz U. Clin Pharmacokinet, 2000; 38 : 243 - 270
  • 3Chang M, Tybring G, Dahl ML, et al. Br J Clin Pharmacol,1995;39:511-518
  • 4Furuta T, Ohashi K, Kosuge K, et al. Clin Pharmacol Ther,1999 ;65 : 552-561
  • 5Sagar M, Bertilsson L, Stridsberg M, et al. Aliment Pharmacol Ther,2000 ; 14: 1495-1502
  • 6Lehmann FS, Hildebrand P,Beglinger C. Drugs,2003;63:1785- 1797
  • 7Sagar M, Janczewska I, Ljungdahl A, et al. Aliment Pharmacol Ther, 1999 ; 13:453-458
  • 8Howden CW. J Clin Gastroenterol,2000;30:29-33
  • 9Furuta T,Ohashi K, Kamata T,et al. Ann Intern Med,1998;129:1027- 1030L
  • 10Aoyama N,Tanigawara Y,Kita T,et al. J Gastroenterol,1999;34 : 80- 83

共引文献17

同被引文献13

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部